Vivamedicus - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 92,459 | 208,536 | 218,212 | 407,418 | 514,710 | 407,732 | 410,014 | 272,346 |
| Profit before tax | 71,017 | 108,971 | 91,285 | 138,226 | 144,774 | 75,669 | 108,478 | 38,047 |
| Net profit | 67,430 | 103,493 | 86,709 | 117,409 | 124,118 | 64,112 | 92,003 | 31,860 |
| Equity | 70,180 | 106,243 | 110,599 | 169,184 | 178,597 | 140,980 | 115,336 | 93,672 |
| Liabilities | 4,709 | 16,126 | 8,567 | 92,670 | 45,916 | 64,599 | 19,900 | 32,313 |
| Non-current assets | 8,867 | 7,917 | 13,541 | 86,362 | 68,178 | 38,314 | 31,818 | 45,875 |
| Current assets | 65,857 | 114,304 | 105,369 | 175,144 | 156,039 | 166,238 | 102,506 | 79,130 |
| Total assets | 74,724 | 122,221 | 118,910 | 261,506 | 224,217 | 204,552 | 134,324 | 125,005 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 91,580 | 80,510 | 59,809 |
| Social insurance contributions | - | - | - | - | - | 14,220 | 20,098 | 12,494 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +304.1% | +125.5% | +4.6% | +86.7% | +26.3% | -20.8% | +0.6% | -33.6% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 90.2% | 84.7% | 72.9% | 44.9% | 55.4% | 31.3% | 68.5% | 25.5% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 96.1% | 97.4% | 78.4% | 69.4% | 69.5% | 45.5% | 79.8% | 34.0% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 72.9% | 49.6% | 39.7% | 28.8% | 24.1% | 15.7% | 22.4% | 11.7% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 76.8% | 52.3% | 41.8% | 33.9% | 28.1% | 18.6% | 26.5% | 14.0% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.1 | 0.2 | 0.1 | 0.5 | 0.3 | 0.5 | 0.2 | 0.3 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 92,459 | 104,268 | 109,106 | 47,010 | 53,709 | 39,779 | 50,724 | 33,348 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Vivamedicus - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-08-26 | 2026-08-29 | 0.19 |
| 2026-08-23 | 2026-08-23 | 0.19 |
| 2026-08-19 | 2026-08-19 | 0.19 |
| 2026-07-23 | 2026-08-12 | 0.19 |
| 2024-04-23 | 2024-05-08 | 0.41 |
| 2023-07-26 | 2023-08-10 | 0.92 |
| 2023-07-24 | 2023-07-25 | 0.99 |
| 2023-05-04 | 2023-05-07 | 2.82 |
| 2023-04-25 | 2023-04-25 | 2.82 |
| 2023-03-16 | 2023-03-20 | 19.74 |
| 2023-01-17 | 2023-01-23 | 1177.08 |
| 2021-11-16 | 2021-12-05 | 0.02 |
| 2021-10-18 | 2021-10-20 | 0.02 |
Vivamedicus - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-09-28 | 2025-09-29 | 3319.37 |
| 2025-08-28 | 2025-08-28 | 2846.71 |
| 2025-07-28 | 2025-07-28 | 2200.49 |
| 2025-05-17 | 2025-05-17 | 4869.01 |
| 2025-05-09 | 2025-05-16 | 4637.87 |
| 2025-02-23 | 2025-02-26 | 22.04 |
| 2025-02-20 | 2025-02-22 | 22.0 |
| 2025-02-13 | 2025-02-13 | 3074.94 |
| 2024-11-28 | 2024-12-08 | 1.18 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Vivamedicus, UAB (code 304411429) is a Private Limited Liability Company engaged in medical specialists activities. In the latest financial year, 2025, the company generated revenue of €272.3K and net profit of €31.9K, corresponding to a profit margin of 11.7%. Revenue declined by 33.6% year on year and was also 33.2% below the 2023 level, showing a clear contraction after a stronger 2024. The profit trend followed the same direction: net profit increased from €64.1K in 2023 to €92.0K in 2024, then eased to €31.9K in 2025. Total assets at year-end 2025 amounted to €125.0K, supported by equity of €93.7K and liabilities of €32.3K. The equity ratio remained high at 74.9%, while debt to equity stood at 0.34. Asset turnover was 2.18x, indicating efficient use of the asset base. Revenue per employee was €34.0K and profit per employee was €4.0K.